Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-09-16 | 2022-04-21 | 145780 |
TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2022-06-09 | 2022-06-17 | 162283 |
TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2022-12-01 | 2022-12-15 | 176776 |
TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181617 |
TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2023-02-09 | 2023-04-28 | 184189 |
TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2023-04-27 | 2023-11-03 | 190743 |
TEVA-MOXIFLOXACIN | 400MG | TABLET | Actual shortage | 2023-06-08 | 2024-04-11 | 194157 |
TEVA-ACEBUTOLOL | 400MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195142 |
TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195847 |
TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-02-08 | 2024-03-07 | 218983 |
TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-18 | 2024-05-09 | 222572 |
TEVA-TECNAL C 1/4 | 40MG 330MG 15MG 50MG | CAPSULE | Resolved | 2021-03-25 | 2021-06-03 | 136307 |
TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1591 |
TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1609 |
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2021-09-23 | 1724 |
RATIO-ATORVASTATIN | 40MG | TABLET | Actual shortage | 2017-03-13 | 2017-10-10 | 1803 |
TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2017-03-14 | 2017-04-03 | 2301 |
TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-05-10 | 2018-02-21 | 9799 |
TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-05-10 | 2018-07-30 | 9912 |
TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-05-23 | 2018-02-21 | 10899 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |